Krill oil attenuates left ventricular dilatation after myocardial infarction in rats

Lipids in Health and Disease

Volumn 10, Issue 1, 2011, Pages

  Fosshaug, Linn E ^a,b,c   Berge, Rolf K ^d,e   Beitnes, Jan O ^b   Berge, Kjetil ^f   Vik, Hogne ^f   Aukrust, Pål ^b   Gullestad, Lars ^b,c   Vinge, Leif E ^b,c   Oie, Erik ^a,b,c  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f former employee of Aker BioMarine Antarctic AS   (Norway)

Author keywords

Heart failure; Lipids; N 3 polyunsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; KRILL OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MONOUNSATURATED FATTY ACID; NATURAL PRODUCT; OMEGA 3 FATTY ACID; PALMITIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; LIPID; OIL;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EXAMINATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIET SUPPLEMENTATION; ECHOCARDIOGRAPHY; EUPHAUSIA SUPERBA; FOOD INTAKE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART STRESS; HEART VENTRICLE REMODELING; HEART WEIGHT; INFLAMMATION; LIPID COMPOSITION; LUNG WEIGHT; MALE; NONHUMAN; RAT; TREATMENT DURATION; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; HEART; HEART MUSCLE; HEART VENTRICLE; KRILL; LESIONS AND DEFECTS; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALS; CARDIOTONIC AGENTS; DILATATION, PATHOLOGIC; EUPHAUSIACEA; FATTY ACIDS, OMEGA-3; GENE EXPRESSION; HEART; HEART VENTRICLES; LIPIDS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; OILS; ORGAN SIZE; RANDOM ALLOCATION; RATS; RATS, WISTAR; VENTRICULAR REMODELING;

EID: 84855182030     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-245     Document Type: Article

References (31)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008, 29:2388-2442.
2. Mann DL: Mechanisms and models in heart failure: A combinatorial approach. Circulation 1999, 100:999-1008.
3. Neubauer S: The failing heart-an engine out of fuel. N Engl J Med 2007, 356:1140-1151.
4. Stanley WC, Recchia FA, Lopaschuk GD: Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005, 85:1093-1129.
5. Investigators G-P: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSIPrevenzione trial. Lancet 1999, 354:447-455.
6. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1223-1230.
7. Saravanan P, Davidson NC, Schmidt EB, Calder PC: Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010, 376:540-550.
8. Duda MK, O'Shea KM, Stanley WC: omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential. Cardiovasc Res 2009, 84:33-41.
9. Weihrauch JL, Posati LP, Anderson BA, Exler J: Lipid conversion factors for calculating fatty acid contents of foods. J Am Oil Chem Soc 1977, 54:36-40.
10. Lu FS, Nielsen NS, Timm-Heinrich M, Jacobsen C: Oxidative stability of marine phospholipids in the liposomal form and their applications. Lipids 2011, 46:3-23.
11. Cohn JS, Wat E, Kamili A, Tandy S: Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease. Curr Opin Lipidol 2008, 19:257-262.
12. O'Shea KM, Chess DJ, Khairallah RJ, Hecker PA, Lei B, Walsh K, Des Rosiers C, Stanley WC: omega-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in adiponectin. Lipids Health Dis 9:95.
13. Duda MK, O'Shea KM, Lei B, Barrows BR, Azimzadeh AM, McElfresh TE, Hoit BD, Kop WJ, Stanley WC: Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 2007, 76:303-310.
14. Duda MK, O'Shea KM, Tintinu A, Xu W, Khairallah RJ, Barrows BR, Chess DJ, Azimzadeh AM, Harris WS, Sharov VG, Sabbah HN, Stanley WC: Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 2009, 81:319-327.
15. Shah KB, Duda MK, O'Shea KM, Sparagna GC, Chess DJ, Khairallah RJ, Robillard-Frayne I, Xu W, Murphy RC, Des Rosiers C, Stanley WC: The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: role of cardiac phospholipid remodeling. Hypertension 2009, 54:605-611.
16. Ghio S, Scelsi L, Latini R, Masson S, Eleuteri E, Palvarini M, Vriz O, Pasotti M, Gorini M, Marchioli R, Maggioni A, Tavazzi L: Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 2010, 12:1345-1353.
17. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, Dei Cas L: Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 2011, 57:870-879.
18. Spinale FG: Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007, 87:1285-1342.
19. McGrath MF, de Bold ML, de Bold AJ: The endocrine function of the heart. Trends Endocrinol Metab 2005, 16:469-477.
20. Maytin M, Colucci WS: Molecular and cellular mechanisms of myocardial remodeling. J Nucl Cardiol 2002, 9:319-327.
21. Zeghichi-Hamri S, de Lorgeril M, Salen P, Chibane M, de Leiris J, Boucher F, Laporte F: Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats. Nutr Res 2010, 30:849-857.
22. Abdukeyum GG, Owen AJ, McLennan PL: Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning. J Nutr 2008, 138:1902-1909.
23. Hu FB, Manson JE, Willett WC: Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001, 20:5-19.
24. Kong JY, Rabkin SW: Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A. Biochim Biophys Acta 2000, 1485:45-55.
25. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM: Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004, 110:1645-1649.
26. McMillin JB, Bick RJ, Benedict CR: Influence of dietary fish oil on mitochondrial function and response to ischemia. Am J Physiol 1992, 263: H1479-1485.
27. Batetta B, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L, Giordano E, Sanna F, Bisogno T, Uda S, Collu M, Bruheim I, Di Marzo V, Banni S: Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr 2009, 139:1495-1501.
28. Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, Hubacher R, Rains TM: Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res 2009, 29:609-615.
29. Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen JI: Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 2011, 46:37-46.
30. \Oie E, Vinge LE, Tønnessen T, Grøgaard HK, Kjekshus H, Christensen G, Smiseth OA, Attramadal H: Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats. Am J Physiol 1997, 273:H1727-1736.
31. Wergedahl H, Liaset B, Gudbrandsen OA, Lied E, Espe M, Muna Z, Mork S, Berge RK: Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA: cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 2004, 134:1320-1327.